Heritability of Spondyloarthritis (SpA) is highlighted by several familial studies and a high association with the presence of human leukocyte antigen (HLA)-B27. Though it has been over four decades since the association of HLA-B27 with SpA was first determined, the pathophysiological roles played by specific HLA-B27 allotypes are not fully understood. Popular hypotheses include the presentation of arthritogenic peptides, triggering of endoplasmic reticulum (ER) stress by misfolded HLA-B27, and the interaction between free heavy chains or heavy chain homodimers of HLA-B27 and immune receptors to drive IL-17 responses. Several non-HLA susceptibility loci have also been identified for SpA, including endoplasmic reticulum aminopeptidases (ERAP) and those related to the IL-23/IL-17 axes. In this review, we summarize clinical aspects of SpA including known characteristics of gut inflammation, enthesitis and new bone formation and the existing models for understanding the association of HLA-B27 with disease pathogenesis. We also examine newer insights into the biology of HLA class I (HLA-I) proteins and their implications for expanding our understanding of HLA-B27 contributions to SpA pathogenesis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982681 | PMC |
http://dx.doi.org/10.3389/fimmu.2021.601518 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!